Justices Skip Case Horizon Said Puts 32K Patents At Risk
The U.S. Supreme Court on Monday refused to take up Horizon's argument that a divided Federal Circuit decision striking down part of its patented arthritis drug Pennsaid "casts a pall of...To view the full article, register now.
Already a subscriber? Click here to view full article